HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Kawai Selected Research

Synovial Sarcoma (Synovioma)

7/2022Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
1/2022Identification of novel SSX1 fusions in synovial sarcoma.
1/2022Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
10/2021Clinical analysis of multimodal treatment for localized synovial sarcoma: A multicenter retrospective study.
7/2021Efficacy of perioperative chemotherapy for synovial sarcoma: a retrospective analysis of a Nationwide database in Japan.
5/2021Is perioperative chemotherapy recommended in childhood and adolescent patients with synovial sarcoma? A systematic review.
7/2020Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
5/2020Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
12/2018Analysis of mutations in primary and metastatic synovial sarcoma.
4/2018Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Kawai Research Topics

Disease

118Neoplasms (Cancer)
10/2022 - 01/2002
66Sarcoma (Soft Tissue Sarcoma)
05/2022 - 04/2002
36Neoplasm Metastasis (Metastasis)
10/2022 - 07/2004
26Osteosarcoma (Osteogenic Sarcoma)
10/2022 - 08/2008
23Synovial Sarcoma (Synovioma)
07/2022 - 04/2002
12Chondrosarcoma
11/2022 - 01/2002
10Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2013 - 08/2004
7Infections
06/2018 - 05/2010
6Carcinogenesis
01/2022 - 01/2002
5Giant Cell Tumor of Bone
06/2022 - 06/2009
5Ewing Sarcoma (Sarcoma, Ewing)
08/2021 - 04/2009
5Liposarcoma
08/2021 - 02/2017
5Disease Progression
04/2020 - 04/2015
5Leiomyosarcoma
01/2020 - 08/2004
4Fibroma (Fibromatosis)
10/2020 - 08/2004
4Aggressive Fibromatosis (Desmoid)
10/2020 - 08/2004
4Alveolar Soft Part Sarcoma
01/2018 - 05/2014
4Necrosis
01/2016 - 09/2011
3Neurofibrosarcoma (MPNST)
01/2021 - 09/2008
3Dermatofibrosarcoma
07/2020 - 09/2010
3Margins of Excision
11/2019 - 01/2014
3Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2018 - 08/2003
2Pneumothorax
10/2022 - 05/2016
2Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 07/2022
2Rhabdomyosarcoma
04/2022 - 09/2011
2Neutropenia
01/2021 - 10/2020
2Cardiotoxicity
01/2021 - 01/2020
2Leiomyoma (Uterine Fibroids)
10/2019 - 08/2004
2Pain (Aches)
05/2019 - 01/2013
2Giant Cell Tumors (Giant Cell Tumor)
02/2019 - 01/2016
2Clear Cell Sarcoma
06/2017 - 09/2008
2Extraskeletal Myxoid Chondrosarcoma
06/2017 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2017 - 09/2014
2Malignant Fibrous Histiocytoma
06/2015 - 08/2006
2Nausea
04/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2002
26Biomarkers (Surrogate Marker)IBA
06/2022 - 08/2006
15Pharmaceutical PreparationsIBA
07/2022 - 03/2009
14Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 05/2005
10pazopanibFDA Link
01/2021 - 03/2016
9MicroRNAs (MicroRNA)IBA
08/2021 - 06/2011
9TrabectedinIBA
01/2020 - 08/2014
7RNA (Ribonucleic Acid)IBA
01/2022 - 09/2017
7Biological ProductsIBA
01/2020 - 01/2002
6Phosphotransferases (Kinase)IBA
12/2021 - 05/2005
5eribulinFDA Link
05/2022 - 01/2017
5IfosfamideFDA LinkGeneric
10/2021 - 05/2005
5Keratins (Keratin)IBA
12/2019 - 08/2003
5ProteomeIBA
04/2019 - 01/2012
4DenosumabFDA Link
06/2022 - 01/2016
4S100 Proteins (S 100 Protein)IBA
01/2022 - 08/2003
4Monoclonal AntibodiesIBA
01/2022 - 01/2010
4Mucin-1 (CA 15-3 Antigen)IBA
12/2019 - 08/2003
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2022 - 10/2019
3alpha-hydroxyglutarateIBA
11/2022 - 10/2019
3Antineoplastic Agents (Antineoplastics)IBA
07/2022 - 08/2014
3AnthracyclinesIBA
01/2021 - 01/2018
3GemcitabineFDA Link
01/2020 - 08/2014
3Messenger RNA (mRNA)IBA
01/2020 - 09/2014
3DesminIBA
12/2019 - 08/2003
3Contrast MediaIBA
01/2018 - 03/2006
3Imatinib Mesylate (Gleevec)FDA Link
06/2013 - 09/2010
3OligonucleotidesIBA
11/2010 - 07/2007
2Angiogenesis InhibitorsIBA
10/2022 - 03/2009
2A-Form DNA (A-DNA)IBA
01/2022 - 08/2014
2Glial Fibrillary Acidic ProteinIBA
01/2022 - 08/2015
24- (2- fluoro- 4- ((((2- phenylacetyl)amino)thioxomethyl)amino)phenoxy)- 7- methoxy- N- methyl- 6- quinolinecarboxamideIBA
12/2021 - 01/2020
2Histone Deacetylases (Histone Deacetylase)IBA
07/2020 - 11/2004
2Platelet-Derived Growth FactorIBA
07/2020 - 01/2019
2Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
07/2020 - 01/2019
2Small Interfering RNA (siRNA)IBA
05/2020 - 01/2016
2ChromatinIBA
03/2020 - 08/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 05/2005
2Estrogen ReceptorsIBA
10/2019 - 08/2015
2Cisplatin (Platino)FDA LinkGeneric
10/2017 - 01/2016
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2017 - 02/2017
2Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
10/2016 - 03/2010
2Arginine (L-Arginine)FDA Link
10/2016 - 03/2010
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2016 - 11/2010
2VimentinIBA
08/2015 - 08/2003
2Docetaxel (Taxotere)FDA Link
09/2014 - 08/2014
2Oncogene Proteins (Oncogene Protein)IBA
05/2014 - 11/2004
2PeroxiredoxinsIBA
10/2013 - 05/2010

Therapy/Procedure

44Drug Therapy (Chemotherapy)
09/2022 - 05/2005
32Therapeutics
07/2022 - 01/2002
11Radiotherapy
04/2022 - 02/2007
8Prostheses and Implants (Prosthesis)
06/2018 - 08/2008
8Limb Salvage
07/2017 - 10/2005
6Surgical Amputation (Amputations)
06/2018 - 03/2003
6Neoadjuvant Therapy
01/2018 - 07/2009
5Curettage
06/2022 - 10/2005
5Adjuvant Chemotherapy
10/2021 - 12/2015
3Aftercare (After-Treatment)
02/2022 - 10/2012
3Induction Chemotherapy
01/2016 - 02/2007
2Combined Modality Therapy
10/2021 - 01/2020
2Conservative Treatment
10/2020 - 11/2019
2Hemipelvectomy
02/2019 - 10/2005
2Free Tissue Flaps
03/2016 - 03/2014
2Intravenous Injections
01/2016 - 06/2011
2Decompression
11/2015 - 01/2013